Consistent with a role in driving Sertoli cell proliferation and tumour formation, disruption of luteinising hormone (LH) and/or FSH signalling ablates or reduces tumour size (Kumar et al., 1996; Haverfield et al., 2017). Here, BRD2 is linked to neoplasm.